Atara Biotherap(ATRA.US)

Last Updated 19:00:00 ET
longbridge loading

21:12 ETATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit

prnewswire·
US
ATRA
+2.84%
US
IXJ
+0.79%
US
LABU
-2.35%
prnewswire·
US
ATRA
+2.84%
US
IXJ
+0.79%
US
LABU
-2.35%

15:00 ETAtara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

prnewswire·
US
ATRA
+2.84%
US
BBH
+0.68%
US
FBT
+0.54%
prnewswire·
US
ATRA
+2.84%
US
BBH
+0.68%
US
FBT
+0.54%

10:34 ETATRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026

prnewswire·
US
ATRA
+2.84%
US
VHT
+0.97%
US
XBI
-0.69%
prnewswire·
US
ATRA
+2.84%
US
VHT
+0.97%
US
XBI
-0.69%

Atara Biotherapeutics (ATRA) to Release Earnings on Thursday

Market Beat·
US
ATRA
+2.84%
US
ARKG
+0.04%
US
LABU
-2.35%
Market Beat·
US
ATRA
+2.84%
US
ARKG
+0.04%
US
LABU
-2.35%

Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress | ATRA Stock News

StockTitan·
US
ATRA
+2.84%
US
IBB
+0.10%
US
FBT
+0.54%
StockTitan·
US
ATRA
+2.84%
US
IBB
+0.10%
US
FBT
+0.54%

16:41 ETAtara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

prnewswire·
US
ATRA
+2.84%
US
XBI
-0.69%
US
IHE
+1.26%
prnewswire·
US
ATRA
+2.84%
US
XBI
-0.69%
US
IHE
+1.26%

ATRA Crosses Above Average Analyst Target

nasdaq·
US
ATRA
+2.84%
US
SBIO
-1.24%
US
XLV
+1.10%
nasdaq·
US
ATRA
+2.84%
US
SBIO
-1.24%
US
XLV
+1.10%
© 2026 Longbridge｜Disclaimer